Nneka C. Onwudiwe PharmD, PhD, MBA

Nneka C. Onwudiwe, PhD, PharmD, MBA, is the technical expert and point of contact in the review of patient-reported outcomes (PRO), pharmacoeconomics (PE), and other type of claims in prescription drug promotion for the Division of Advertising and Promotion Review II (DAPR II) within the Office of Prescription Drug Promotion at the Food and Drug Administration (FDA). Dr. Onwudiwe received her doctorate in Pharmacy from the University of Maryland School of Pharmacy, PhD in Health Services Research with a specialization in Pharmacoeconomics from the University of Maryland School of Pharmacy, and a MBA (Honors) from the University of Baltimore. In addition, she received an honor of Rho Chi in Pharmacy in 2002 and an honor of Beta Gamma Sigma in Business Administration in 2012.

In addition to her position at the FDA, Dr. Onwudiwe teaches Comparative Effectiveness Research (CER) & Pharmacoeconomics at the University of Maryland School of Pharmacy. Dr. Onwudiwe has received several awards and has been recently nominated for a Service and Excellence Award. She has received funding as a Principal Investigator from NIH/NHLBI. Dr. Onwudiwe currently serves on the Food and Drug Law Institute (FDLI) Update Editorial Advisory Board, as well as the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Value Assessment Frameworks Stakeholder Advisory Panel.